Antibiotics versus placebo or watchful waiting for acute otitis media: A meta-analysis of randomized controlled trials

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 1, 2009, Pages 16-24

  Vouloumanou, Evridiki K ^a   Karageorgopoulos, Drosos E ^a   Kazantzi, Maria S ^a   Kapaskelis, Anastasios M ^a,b   Falagas, Matthew E ^a,b,c  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b HENRY DUNANT HOSPITAL   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Delayed antibiotic treatment; Drug therapy; Ear diseases; Treatment outcome; Upper respiratory tract infections; Wait and see strategy

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; PENICILLIN V; PHENETICILLIN; PLACEBO; SULFAFURAZOLE;

ACUTE OTITIS MEDIA; ANTIBIOTIC THERAPY; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; HUMAN; META ANALYSIS; MIDDLE EAR EFFUSION; OTITIS MEDIA; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; WATCHFUL WAITING;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; HUMANS; INFANT; OTITIS MEDIA; PLACEBOS; TREATMENT OUTCOME;

EID: 67249087946     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp166     Document Type: Review

References (49)

1. Chonmaitree T, Heikkinen T. Role of viruses in middle-ear disease. Ann NY Acad Sci 1997; 830: 143-57.
2. Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med 1999; 340: 260-4.
3. Yano H, Okitsu N, Watanabe O et al. Acute otitis media associated with cytomegalovirus infection in infants and children. Int J Pediatr Otorhinolaryngol 2007; 71: 1443-7.
4. Elden LM, Spiro DM. Acute otitis media-to treat or not to treat? Pediatr Emerg Care 2006; 22: 283-6.
5. American Academy of Pediatrics, American Academy of Family Physicians, Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004; 113: 1451-65.
6. National Institute for Health and Clinical Excellence. Respiratory tract infections - antibiotic prescribing. Prescribing of Antibiotics for Self-limiting Respiratory Tract Infections in Adults and Children in Primary Care. NICE Clinical guideline No.69. 2008. London, UK: National Institute for Health and Clinical Excellence.
7. Arnold SR, Bush AJ. Decline in inappropriate antibiotic use over a decade by pediatricians in a Tennessee community. Ambul Pediatr 2006; 6: 225-9.
8. Cohen R, Levy C, de La Rocque F et al. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Pediatr Infect Dis J 2006; 25: 1001-7.
9. Miller GE, Hudson J. Children and antibiotics: Analysis of reduced use, 1996-2001. Med Care 2006; 44: I36-44.
10. Glasziou PP, Del Mar CB, Sanders SL et al. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev 2004; issue 1: CD000219.
11. Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care 1996; 12: 195-208.
12. Moher D, Pham B, Jones A et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352: 609-13.
13. Higgins JP, Thompson SG, Deeks JJ et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
14. Le Saux N, Gaboury I, Baird M et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Can Med Assoc J 2005; 172: 335-41.
15. Damoiseaux RA, van Balen FA, Hoes AW et al. Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ 2000; 320: 350-4.
16. Appelman CL, Claessen JQ, Touw-Otten FW et al. Co-amoxiclav in recurrent acute otitis media: Placebo controlled study. BMJ 1991; 303: 1450-2.
17. Burke P, Bain J, Robinson D et al. Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ 1991; 303: 558-62.
18. Mygind N, Meistrup-Larsen KI, Thomsen J et al. Penicillin in acute otitis media: A double-blind placebo-controlled trial. Clin Otolaryngol Allied Sci 1981; 6: 5-13.
19. van Buchem FL, Dunk JH, van't Hof MA. Therapy of acute otitis media: myringotomy, antibiotics, or neither? A double-blind study in children. Lancet 1981; ii: 883-7.
20. Halsted C, Lepow ML, Balassanian N et al. Otitis media. Clinical observations, microbiology, and evaluation of therapy. Am J Dis Child 1968; 115: 542-51.
21. Spiro DM, Tay KY, Arnold DH et al. Wait-and-see prescription for the treatment of acute otitis media: A randomized controlled trial. JAMA 2006; 296: 1235-41.
22. McCormick DP, Chonmaitree T, Pittman C et al. Nonsevere acute otitis media: A clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics 2005; 115: 1455-65.
23. Little P, Gould C, Williamson I et al. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ 2001; 322: 336-42.
24. Laxdal OE, Merida J, Jones RH. Treatment of acute otitis media: A controlled study of 142 children. Can Med Assoc J 1970; 102: 263-8.
25. Berman S. Otitis media in children. N Engl J Med 1995; 332: 1560-5.
26. Vernacchio L, Vezina RM, Mitchell AA. Management of acute otitis media by primary care physicians: Trends since the release of the 2004 American Academy of Pediatrics/American Academy of Family Physicians clinical practice guideline. Pediatrics 2007; 120: 281-7.
27. Gates GA. Cost-effectiveness considerations in otitis media treatment. Otolaryngol Head Neck Surg 1996; 114: 525-30.
28. Greenberg D, Bilenko N, Liss Z et al. The burden of acute otitis media on the patient and the family. Eur J Pediatr 2003; 162 576-81.
29. Meropol SB. Valuing reduced antibiotic use for pediatric acute otitis media. Pediatrics 2008; 121: 669-73.
30. Falagas ME, Giannopoulou KP, Vardakas KZ et al. Comparison of antibiotics with placebo for treatment of acute sinusitis: A meta-analysis of randomised controlled trials. Lancet Infect Dis 2008; 8: 543-52.
31. Goldstein NA, Casselbrant ML, Bluestone CD et al. Intratemporal complications of acute otitis media in infants and children. Otolaryngol Head Neck Surg 1998; 119: 444-54.
32. Kangsanarak J, Fooanant S, Ruckphaopunt K et al. Extracranial and intracranial complications of suppurative otitis media. Report of 102 cases. J Laryngol Otol 1993; 107: 999-1004.
33. Thompson PL, Gilbert RE, Long PF et al. Effect of antibiotics for otitis media on mastoiditis in children: A retrospective cohort study using the United Kingdom general practice research database. Pediatrics 2009; 123: 424-30.
34. Van Zuijlen DA, Schilder AG, Van Balen FA et al. National differences in incidence of acute mastoiditis: Relationship to prescribing patterns of antibiotics for acute otitis media? Pediatr Infect Dis J 2001; 20: 140-4.
35. Dagan R, Leibovitz E, Greenberg D et al. Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome. Pediatr Infect Dis J 1998; 17: 776-82.
36. Chastre J, Wolff M, Fagon JY et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: A randomized trial. JAMA 2003; 290: 2588-98.
37. Houck PM, Bratzler DW, Nsa W et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004; 164: 637-44.
38. Ibrahim EH, Sherman G, Ward S et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146-55.
39. Greenberg D, Hoffman S, Leibovitz E et al. Acute otitis media in children: Association with day care centers-antibacterial resistance, treatment, and prevention. Paediatr Drugs 2008; 10: 75-83.
40. Vanderkooi OG, Low DE, Green K et al. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 2005; 40: 1288-97.
41. Metlay JP, Hofmann J, Cetron MS et al. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2000; 30: 520-8.
42. Huang SS, Finkelstein JA, Lipsitch M. Modeling community- and individual-level effects of child-care center attendance on pneumococcal carriage. Clin Infect Dis 2005; 40: 1215-22.
43. Kwan-Gett TS, Davis RL, Shay DK et al. Is household antibiotic use a risk factor for antibiotic-resistant pneumococcal infection? Epidemiol Infect 2002; 129: 499-505.
44. Pichichero ME, Casey JR. Comparison of study designs for acute otitis media trials. Int J Pediatr Otorhinolaryngol 2008; 72: 737-50.
45. Pichichero ME, Casey JR. Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era. Pediatr Infect Dis J 2007; 26: S12-6.
46. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 2007; 298: 1772-8.
47. Meropol SB, Glick HA, Asch DA. Age inconsistency in the American Academy of Pediatrics guidelines for acute otitis media. Pediatrics 2008; 121: 657-68.
48. Rovers MM, Glasziou P, Appelman CL et al. Predictors of pain and/ or fever at 3 to 7 days for children with acute otitis media not treated initially with antibiotics: A meta-analysis of individual patient data. Pediatrics 2007; 119: 579-85.
49. Rovers MM, Glasziou P, Appelman CL et al. Antibiotics for acute otitis media: A meta-analysis with individual patient data. Lancet 2006; 368 1429-35.